Peir‐In Liang

1.2k total citations
64 papers, 884 citations indexed

About

Peir‐In Liang is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Peir‐In Liang has authored 64 papers receiving a total of 884 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Surgery, 28 papers in Molecular Biology and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Peir‐In Liang's work include Bladder and Urothelial Cancer Treatments (24 papers), Ferroptosis and cancer prognosis (11 papers) and Epigenetics and DNA Methylation (11 papers). Peir‐In Liang is often cited by papers focused on Bladder and Urothelial Cancer Treatments (24 papers), Ferroptosis and cancer prognosis (11 papers) and Epigenetics and DNA Methylation (11 papers). Peir‐In Liang collaborates with scholars based in Taiwan, United States and United Kingdom. Peir‐In Liang's co-authors include Chien‐Feng Li, Wen‐Jeng Wu, Wei‐Ming Li, Hung‐Lung Ke, Hsin‐Chih Yeh, Chun‐Nung Huang, Bi‐Wen Yeh, Tingfeng Wu, I‐Wei Chang and Ching‐Chia Li and has published in prestigious journals such as PLoS ONE, Scientific Reports and The FASEB Journal.

In The Last Decade

Peir‐In Liang

60 papers receiving 873 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peir‐In Liang Taiwan 19 356 239 222 172 151 64 884
Dae Hyun Song South Korea 19 465 1.3× 146 0.6× 193 0.9× 195 1.1× 220 1.5× 90 1.1k
Sien‐Yi Sheu Germany 19 263 0.7× 283 1.2× 218 1.0× 196 1.1× 152 1.0× 50 1.0k
Victoria Bingham United Kingdom 22 581 1.6× 192 0.8× 430 1.9× 257 1.5× 163 1.1× 46 1.4k
Junhui Sun China 17 218 0.6× 207 0.9× 174 0.8× 140 0.8× 196 1.3× 68 1.1k
M. Herman Chui United States 17 352 1.0× 98 0.4× 307 1.4× 197 1.1× 143 0.9× 50 964
Francesco Vasuri Italy 22 469 1.3× 424 1.8× 260 1.2× 303 1.8× 231 1.5× 125 1.5k
Liyan Xue China 17 507 1.4× 160 0.7× 263 1.2× 211 1.2× 305 2.0× 50 922
Shigeto Maeda Japan 18 536 1.5× 299 1.3× 535 2.4× 183 1.1× 189 1.3× 63 1.5k
Alessandro Bombonati United States 15 340 1.0× 109 0.5× 283 1.3× 299 1.7× 82 0.5× 21 843
Sheng Li China 20 235 0.7× 103 0.4× 425 1.9× 160 0.9× 120 0.8× 57 786

Countries citing papers authored by Peir‐In Liang

Since Specialization
Citations

This map shows the geographic impact of Peir‐In Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peir‐In Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peir‐In Liang more than expected).

Fields of papers citing papers by Peir‐In Liang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peir‐In Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peir‐In Liang. The network helps show where Peir‐In Liang may publish in the future.

Co-authorship network of co-authors of Peir‐In Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Peir‐In Liang. A scholar is included among the top collaborators of Peir‐In Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peir‐In Liang. Peir‐In Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Hugo You‐Hsien, Yu-Han Chang, Peir‐In Liang, et al.. (2023). Thiazide and thiazide-like diuretics associated with improved cardiovascular and renal outcomes for chronic kidney disease patients. Annals of the Academy of Medicine Singapore. 52(10). 510–521. 1 indexed citations
2.
Lin, Hugo You‐Hsien, Yu-Han Chang, Peir‐In Liang, et al.. (2023). Thiazide and thiazide-like diuretics are associated with improved cardiovascular and renal outcomes in patients with chronic kidney disease. Annals of the Academy of Medicine Singapore. 52(10 - Correct DOI). 510–521. 1 indexed citations
3.
Liang, Peir‐In, Wei‐Chou Lin, Mei‐Chin Wen, et al.. (2023). Learning more from the inter-rater reliability of interstitial fibrosis assessment beyond just a statistic. Scientific Reports. 13(1). 13260–13260. 3 indexed citations
4.
Liang, Peir‐In, Ti‐Chun Chan, Wei‐Ming Li, et al.. (2023). Upregulation of dihydropyrimidinase-like 3 (DPYSL3) protein predicts poor prognosis in urothelial carcinoma. BMC Cancer. 23(1). 599–599. 3 indexed citations
5.
Niu, Sheng‐Wen, Chi‐Chih Hung, Hugo You‐Hsien Lin, et al.. (2022). Reduced Incidence of Stroke in Patients with Gout Using Benzbromarone. Journal of Personalized Medicine. 12(1). 28–28. 7 indexed citations
6.
Chen, I‐Chen, Yi‐Ching Liu, Jong‐Hau Hsu, et al.. (2022). Congenital Surfactant C Deficiency with Pulmonary Hypertension—A Case Report. Children. 9(10). 1435–1435. 1 indexed citations
7.
Liang, Peir‐In, Fei Wu, Yi Chu, et al.. (2021). Metabolic derangement in polycystic kidney disease mouse models is ameliorated by mitochondrial-targeted antioxidants. Communications Biology. 4(1). 1200–1200. 21 indexed citations
8.
Yang, Chengkun, Ching-Yi Lee, Shun‐Chen Huang, et al.. (2021). Glomerular disease classification and lesion identification by machine learning. Biomedical Journal. 45(4). 675–685. 42 indexed citations
9.
He, Ziyi, et al.. (2021). P13.15 Pre-clinical trial of T601 oncolytic virus for high grade glima via intra-tumoral injection. Neuro-Oncology. 23(Supplement_2). ii35–ii36.
10.
Liang, Peir‐In, et al.. (2020). Low Galectin-3 Expression Level in Primary Tumors Is Associated with Metastasis in T1 Lung Adenocarcinoma. Journal of Clinical Medicine. 9(6). 1990–1990. 4 indexed citations
11.
Li, Wei‐Ming, Ti‐Chun Chan, Steven K. Huang, et al.. (2020). Prognostic Utility of FBLN2 Expression in Patients With Urothelial Carcinoma. Frontiers in Oncology. 10. 570340–570340. 9 indexed citations
12.
Liang, Peir‐In, et al.. (2020). Cytomegalovirus colitis with presentation of hemorrhagic colitis in chronic myeloid leukemia during dasatinib therapy. Journal of the Formosan Medical Association. 120(4). 1155–1157. 5 indexed citations
13.
Lee, Yi‐Chen, Peir‐In Liang, Lin‐Li Chang, et al.. (2019). CSF-1 Overexpression Predicts Poor Prognosis in Upper Tract Urothelial Carcinomas. Disease Markers. 2019. 1–9. 13 indexed citations
14.
Chan, Ti‐Chun, Yufeng Tian, Peir‐In Liang, et al.. (2019). High expression of Chitinase 3-like-1 is an unfavorable prognostic factor in urothelial carcinoma of upper urinary tract and urinary bladder. Urologic Oncology Seminars and Original Investigations. 37(5). 299.e7–299.e18. 9 indexed citations
15.
Chang, Ming‐Min, Marcelo Chen, Peir‐In Liang, et al.. (2018). Glycine N-methyltransferase inhibits aristolochic acid nephropathy by increasing CYP3A44 and decreasing NQO1 expression in female mouse hepatocytes. Scientific Reports. 8(1). 6960–6960. 15 indexed citations
16.
Chang, I‐Wei, Yuhui Wang, Wen‐Jeng Wu, et al.. (2016). Necdin Overexpression Predicts Poor Prognosis in Patients with Urothelial Carcinomas of the Upper Urinary Tract and Urinary Bladder. Journal of Cancer. 7(3). 304–313. 10 indexed citations
17.
Yeh, Hsin‐Chih, Wen‐Jeng Wu, Ching‐Chia Li, et al.. (2016). Is preoperative anemia a risk factor for upper tract urothelial carcinoma following radical nephroureterectomy?. Urologic Oncology Seminars and Original Investigations. 34(8). 337.e1–337.e9. 10 indexed citations
18.
Yeh, Hsin‐Chih, Wen‐Jeng Wu, Ching‐Chia Li, et al.. (2015). Concurrent Preoperative Presence of Hydronephrosis and Flank Pain Independently Predicts Worse Outcome of Upper Tract Urothelial Carcinoma. PLoS ONE. 10(10). e0139624–e0139624. 17 indexed citations
19.
Lee, Hsiang‐Ying, Ching‐Chia Li, Chun‐Nung Huang, et al.. (2014). INHBA overexpression indicates poor prognosis in urothelial carcinoma of urinary bladder and upper tract. Journal of Surgical Oncology. 111(4). 414–422. 36 indexed citations
20.
Liang, Peir‐In, Chien‐Feng Li, Li‐Tzong Chen, et al.. (2013). BCL6 overexpression is associated with decreased p19ARF expression and confers an independent prognosticator in gallbladder carcinoma. Tumor Biology. 35(2). 1417–1426. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026